Targeting of the prion protein to the cytosol: Mechanisms and consequences

Current Issues in Molecular Biology

Volumn 12, Issue 2, 2010, Pages 109-118

  Miesbauer, Margit ^a   Rambold, Angelika S ^a,b   Winklhofer, Konstanze F ^a   Tatzelt, Jörg ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; PRION;

BIOGENESIS; CYTOSOL; ENDOPLASMIC RETICULUM; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN SECRETION; PROTEIN TARGETING; QUALITY CONTROL; REVIEW; ANIMAL; BIOLOGICAL MODEL; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PRION; PRION DISEASE; PROTEIN TRANSPORT;

MUS MUSCULUS; SCRAPIE PRION;

ANIMALS; CYTOSOL; ENDOPLASMIC RETICULUM; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; MODELS, BIOLOGICAL; PRION DISEASES; PRIONS; PROTEIN TRANSPORT;

EID: 74749094150     PISSN: 14673037     EISSN: None     Source Type: Journal    
DOI: 10.21775/9781912530076.05     Document Type: Review

References (103)

1. Aguzzi, A., and Polymenidou, M. (2004). Mammalian prion biology: one century of evolving concepts. Cell 116, 313-327.
2. Amthauer, R., Kodukula, K., Gerber, L., and Udenfriend, S. (1993). Evidence that the putative COOH-terminal signal transamidase involved in glycosylphosphatidylinositol protein synthesis is present in the endoplasmic reticulum. Proc Natl Acad Sci U S A 90, 3973-3977.
3. Ashok, A., and Hegde, R.S. (2009). Selective processing and metabolism of disease-causing mutant prion proteins. PLoS Pathog 5, e1000479.
4. Baumann, F., Tolnay, M., Brabeck, C., Pahnke, J., Kloz, U., Niemann, H.H., Heikenwalder, M., Rulicke, T., Burkle, A., and Aguzzi, A. (2007). Lethal recessive myelin toxicity of prion protein lacking its central domain. Embo J 26, 538-547.
5. Blochberger, T.C., Cooper, C., Peretz, D., Tatzelt, J., Griffith, O.H., Baldwin, M.A., and Prusiner, S.B. (1997). Prion protein expression in Chinese hamster ovary cells using a glutamine synthetase selection and amplification system. Protein Eng 10, 1465-1473.
6. Bolton, D.C., McKinley, M.P., and Prusiner, S.B. (1982). Identification of a protein that purifies with the scrapie prion. Science 218, 1309-1311.
7. Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., and Aguzzi, A. (1996). Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343.
8. Brown, D.R., Schmidt, B., and Kretzschmar, H.A. (1996). Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380, 345-347.
9. Caughey, B., and Lansbury, P.T. (2003). Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26, 267-298.
10. Caughey, B.W., Dong, A., Bhat, K.S., Ernst, D., Hayes, S.F., and Caughey, W.S. (1991). Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30, 7672-7680.
11. Chakrabarti, O., and Hegde, R.S. (2009). Functional depletion of mahogunin by cytosolically exposed prion protein contributes to neurodegeneration. Cell 137, 1136-1147.
12. Chesebro, B. (2003). Introduction to the transmissible spongiform encephalopathies or prion diseases. British medical bulletin 66, 1-20.
13. Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., LaCasse, R., Raymond, L., Favara, C., Baron, G., Priola, S., et al. (2005). Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435-1439.
14. Chiesa, R., Piccardo, P., Ghetti, B., and Harris, D.A. (1998). Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21, 1339-1351.
15. Ciechanover, A., and Brundin, P. (2003). The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40, 427-446.
16. Ciechanover, A., Orian, A., and Schwartz, A.L. (2000). Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays 22, 442-451.
17. Collinge, J. (2001). Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24, 519-550.
18. Deli, M.A., Sakaguchi, S., Nakaoke, R., Abraham, C.S., Takahata, H., Kopacek, J., Shigematsu, K., Katamine, S., and Niwa, M. (2000). PrP fragment 106-126 is toxic to cerebral endothelial cells expressing PrP(C). Neuroreport 11, 3931-3936.
19. Donne, D.G., Viles, J.H., Groth, D., Mehlhorn, I., James, T.L., Cohen, F.E., Prusiner, S.B., Wright, P.E., and Dyson, H.J. (1997). Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci USA 94, 13452-13457.
20. Drisaldi, B., Stewart, R.S., Adles, C., Stewart, L.R., Quaglio, E., Biasini, E., Fioriti, L., Chiesa, R., and Harris, D.A. (2003). Mutant PrP Is Delayed in Its Exit from the Neither Wild-type nor Mutant PrP Undergoes Proteasomal Degradation. J Biol Chem 278, 21732-21743.
21. Eisenhaber, B., Bork, P., and Eisenhaber, F. (1998). Sequence properties of GPI-anchored proteins near the omega-site: constraints for the polypeptide binding site of the putative transamidase. Protein Eng 11, 1155-1161.
22. Ellgaard, L., and Helenius, A. (2003). Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4, 181-191.
23. Englund, P.T. (1993). The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors. Annu Rev Biochem 62, 121-138.
24. Ferguson, M.A.J., and Williams, A.F. (1988). Cell-surface anchoring of protein via glycosyl-phosphatidylinositol structures. Annu Rev Biochem 57, 285-320.
25. Fioriti, L., Dossena, S., Stewart, L.R., Stewart, R.S., Harris, D.A., Forloni, G., and Chiesa, R. (2005). Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J Biol Chem 280, 11320-11328.
26. Flechsig, E., Hegyi, I., Leimeroth, R., Zuniga, A., Rossi, D., Cozzio, A., Schwarz, P., Rulicke, T., Gotz, J., Aguzzi, A., et al. (2003). Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia. Embo J 22, 3095-3101.
27. Fons, R.D., Bogert, B.A., and Hegde, R.S. (2003). Substrates-pecific function of the translocon-associated protein complex during translocation across the ER membrane. J Cell Biol 160, 529-539.
28. Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O., and Tagliavini, F. (1993). Neurotoxicity of a prion protein fragment. Nature 362, 543-546.
29. Gilmore, R., Blobel, G., and Walter, P. (1982a). Protein translocation across the endoplasmic reticulum. I. Detection in the microsomal membrane of a receptor for the signal recognition particle. J Cell Biol 95, 463-469.
30. Gilmore, R., Walter, P., and Blobel, G. (1982b). Protein translocation across the endoplasmic reticulum. II. Isolation and characterization of the signal recognition particle receptor. J Cell Biol 95, 470-477.
31. Gu, Y., Singh, A., Bose, S., and Singh, N. (2008). Pathogenic mutations in the glycosylphosphatidylinositol signal peptide of PrP modulate its topology in neuroblastoma cells. Mol Cell Neurosci 37, 647-656.
32. Haass, C., and Selkoe, D.J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112.
33. Haïk, S., Peyrin, J.M., Lins, L., Rosseneu, M.Y., Brasseur, R., Langeveld, J.P., Tagliavini, F., Deslys, J.P., Lasmézas, C., and Dormont, D. (2000). Neurotoxicity of the Putative Transmembrane Domain of the Prion Protein. Neurobiol Dis 7, 644-656.
34. Hegde, R.S., and Bernstein, H.D. (2006). The surprising complexity of signal sequences. Trends Biochem Sci 31, 563-571.
35. Hegde, R.S., Mastrianni, J.A., Scott, M.R., DeFea, K.A., Tremblay, P., Torchia, M., DeArmond, S.J., Prusiner, S.B., and Lingappa, V.R. (1998). A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827-834.
36. Heller, U., Winklhofer, K.F., Heske, J., Reintjes, A., and Tatzelt, J. (2003). Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain. J Biol Chem 278, 36139-36147.
37. Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu Rev Biochem 67, 425-479.
38. Heske, J., Heller, U., Winklhofer, K.F., and Tatzelt, J. (2004). The C-terminal domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum. J Biol Chem 279, 5435-5443.
39. Hill, A.F., Joiner, S., Linehan, J., Desbruslais, M., Lantos, P.L., and Collinge, J. (2000). Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A 97, 10248-10253.
40. Holscher, C., Bach, U.C., and Dobberstein, B. (2001). Prion protein contains a second endoplasmic reticulum targeting signal sequence located at its C terminus. J Biol Chem 276, 13388-13394.
41. Kang, S.W., Rane, N.S., Kim, S.J., Garrison, J.L., Taunton, J., and Hegde, R.S. (2006). Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway. Cell 127, 999-1013.
42. Kim, S.J., and Hegde, R.S. (2002). Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel. Mol Biol Cell 13, 3775-3786.
43. Kim, S.J., Rahbar, R., and Hegde, R.S. (2001). Combinatorial control of prion protein biogenesis by the signal sequence and transmembrane domain. J Biol Chem 276, 26132-26140.
44. Kodukula, K., Gerber, L.D., Amthauer, R., Brink, L., and Udenfriend, S. (1993). Biosynthesis of glycosylphosphatidylinositol (GPI)-anchored membrane proteins in intact cells: specific amino acid requirements adjacent to the site of cleavage and GPI attachment. J Cell Biol 120, 657-664.
45. Kornfeld, R., and Kornfeld, S. (1985). Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54, 631-664.
46. Kristiansen, M., Deriziotis, P., Dimcheff, D.E., Jackson, G.S., Ovaa, H., Naumann, H., Clarke, A.R., van Leeuwen, F.W., Menendez-Benito, V., Dantuma, N.P., et al. (2007). Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 26, 175-188.
47. Kurschner, C., and Morgan, J.I. (1995). The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res Mol Brain Res 30, 165-168.
48. Kurschner, C., and Morgan, J.I. (1996). Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. Brain Res Mol Brain Res 37, 249-258.
49. Li, A., Christensen, H.M., Stewart, L.R., Roth, K.A., Chiesa, R., and Harris, D.A. (2007). Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. Embo J 26, 548-558.
50. Lin, B., Kolluri, S.K., Lin, F., Liu, W., Han, Y.H., Cao, X., Dawson, M.I., Reed, J.C., and Zhang, X.K. (2004). Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116, 527-540.
51. Lopez, C.D., Yost, C.S., Prusiner, S.B., Myers, R.M., and Lingappa, V.R. (1990). Unusual topogenic sequence directs prion protein biogenesis. Science 248, 226-229.
52. Ma, J., and Lindquist, S. (2001). Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci U S A 98, 14955-14960.
53. Ma, J., Wollmann, R., and Lindquist, S. (2002). Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298, 1781-1785.
54. Malhotra, J.D., and Kaufman, R.J. (2007). The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol 18, 716-731.
55. Mallucci, G., Dickinson, A., Linehan, J., Klohn, P.C., Brandner, S., and Collinge, J. (2003). Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874.
56. Martoglio, B., and Dobberstein, B. (1998). Signal sequences: more than just greasy peptides. Trends Cell Biol 8, 410-415.
57. Meusser, B., Hirsch, C., Jarosch, E., and Sommer, T. (2005). ERAD: the long road to destruction. Nat Cell Biol 7, 766-772.
58. Meyer, D.I., and Dobberstein, B. (1980). Identification and characterization of a membrane component essential for the translocation of nascent proteins across the membrane of the endoplasmic reticulum. J Cell Biol 87, 503-508.
59. Meyer, R.K., McKinley, M.P., Bowman, K.A., Braunfeld, M.B., Barry, R.A., and Prusiner, S.B. (1986). Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci USA 83, 2310-2314.
60. Miesbauer, M., Pfeiffer, N.V., Rambold, A.S., Muller, V., Kiachopoulos, S., Winklhofer, K.F., and Tatzelt, J. (2009). Alpha-helical domains promote translocation of intrinsically disordered polypeptides into the endoplasmic reticulum. J Biol Chem 284, 24384-24393.
61. Mironov, A.J., Latawiec, D., Wille, H., Bouzamondo-Bernstein, E., Legname, G., Williamson, R.A., Burton, D., DeArmond, S.J., Prusiner, S.B., and Peters, P.J. (2003). Cytosolic prion protein in neurons. J Neurosci 23, 7183-7193.
62. Moran, P., Raab, H., Kohr, W.J., and Caras, I.W. (1991). Glycophospholipid membrane anchor attachment. Molecular analysis of the cleavage/attachment site. J Biol Chem 266, 1250-1257.
63. Morimoto, R.I. (2008). Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 22, 1427-1438.
64. Muramoto, T., DeArmond, S.J., Scott, M., Telling, G.C., Cohen, F.E., and Prusiner, S.B. (1997). Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an a-helix. Nat Med 3, 750-755.
65. Nakatsukasa, K., and Brodsky, J.L. (2008). The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum. Traffic 9, 861-870.
66. Nuoffer, C., Horvath, A., and Riezman, H. (1993). Analysis of the sequence requirements for glycosylphosphatidylinositol anchoring of Saccharomyces cerevisiae Gas1 protein. J Biol Chem 268, 10558-10563.
67. Nuoffer, C., Jeno, P., Conzelmann, A., and Riezman, H. (1991). Determinants for glycophospholipid anchoring of the Saccharomyces cerevisiae GAS1 protein to the plasma membrane. Mol Cell Biol 11, 27-37.
68. Orsi, A., Fioriti, L., Chiesa, R., and Sitia, R. (2006). Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein. J Biol Chem 281, 30431-30438.
69. Oyadomari, S., Yun, C., Fisher, E.A., Kreglinger, N., Kreibich, G., Oyadomari, M., Harding, H.P., Goodman, A.G., Harant, H., Garrison, J.L., et al. (2006). Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload. Cell 126, 727-739.
70. Pan, K.-M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R.J., Cohen, F.E., et al. (1993). Conversion of a-helices into b-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90, 10962-10966.
71. Pickart, C.M. (2001). Mechanisms underlying ubiquitination. Annu Rev Biochem 70, 503-533.
72. Prusiner, S.B., Scott, M.R., DeArmond, S.J., and Cohen, F.E. (1998). Prion protein biology. Cell 93, 337-348.
73. Rambold, A.S., Miesbauer, M., Rapaport, D., Bartke, T., Baier, M., Winklhofer, K.F., and Tatzelt, J. (2006). Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP. Mol Biol Cell 17, 3356-3368.
74. Rambold, A.S., Müller, V., Ron, U., Ben-Tal, N., Winklhofer, K.F., and Tatzelt, J. (2008). Stress-protective activity of prion protein is corrupted by scrapie-prions. Embo J 27, 1974-1984.
75. Rane, N.S., Yonkovich, J.L., and Hegde, R.S. (2004). Protection from cytosolic prion protein toxicity by modulation of protein translocation. Embo J 23, 4550-4559.
76. Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., and Wuthrich, K. (1996). NMR structure of the mouse prion protein domain PrP(121-321). Nature 382, 180-182.
77. Riek, R., Hornemann, S., Wider, G., Glockshuber, R., and Wuthrich, K. (1997). NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 413, 282-288.
78. Rogers, M., Yehiely, F., Scott, M., and Prusiner, S.B. (1993). Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. Proc Natl Acad Sci U S A 90, 3182-3186.
79. Ron, D., and Walter, P. (2007). Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8, 519-529.
80. Roucou, X., Guo, Q., Zhang, Y., Goodyer, C.G., and LeBlanc, A.C. (2003). Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J Biol Chem 278, 40877-40881.
81. Rutkowski, D.T., Kang, S.W., Goodman, A.G., Garrison, J.L., Taunton, J., Katze, M.G., Kaufman, R.J., and Hegde, R.S. (2007). The role of p58IPK in protecting the stressed endoplasmic reticulum. Mol Biol Cell 18, 3681-3691.
82. Shmerling, D., Hegyi, I., Fischer, M., Blättler, T., Brandner, S., Götz, J., Rülicke, T., Flechsig, E., Cozzio, A., von Mehring, C., et al. (1998). Expression of animo-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93, 203-214.
83. Stahl, N., Borchelt, D.R., Hsiao, K., and Prusiner, S.B. (1987). Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229-240.
84. Stewart, R.S., Drisaldi, B., and Harris, D.A. (2001). A Transmembrane Form of the Prion Protein Contains an Uncleaved Signal Peptide and Is Retained in the Endoplasmic Reticululm. Mol Biol Cell 12, 881-889.
85. Stewart, R.S., Piccardo, P., Ghetti, B., and Harris, D.A. (2005). Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J Neurosci 25, 3469-3477.
86. Tagliavini, F., Prelli, F., Verga, L., Giaccone, G., Sarma, R., Gorevic, P., Ghetti, B., Passerini, F., Ghibaudi, E., Forloni, G., et al. (1993). Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A 90, 9678-9682.
87. Tatzelt, J., and Winklhofer, K.F. (2004). Folding and misfolding of the prion protein in the secretory pathway. Amyloid 11, 162-172.
88. Udenfriend, S., and Kodukula, K. (1995). How glycosylphosphatidylinositol-anchored membrane proteins are made. Annu Rev Biochem 64, 563-591.
89. Uelhoff, A., Tatzelt, J., Aguzzi, A., Winklhofer, K.F., and Haass, C. (2005). A pathogenic PrP mutation and doppel interfere with polarized sorting of the prion protein. J Biol Chem 280, 5137-5140.
90. von Heijne, G. (1985). Signal sequences. The limits of variation. Journal of molecular biology 184, 99-105.
91. Walmsley, A.R., Zeng, F.N., and Hooper, N.M. (2001). Membrane topology influences N-glycosylation of the prion protein. Embo J 20, 703-712.
92. Walter, P., and Blobel, G. (1980). Purification of a membrane-associated protein complex required for protein translocation across the endoplasmic reticulum. Proc Natl Acad Sci U S A 77, 7112-7116.
93. Walter, P., and Blobel, G. (1982). Signal recognition particle contains a 7S RNA essential for protein translocation across the endoplasmic reticulum. Nature 299, 691-698.
94. Walter, P., Gilmore, R., and Blobel, G. (1984). Protein translocation across the endoplasmic reticulum. Cell 38, 5-8.
95. Wang, X., Bowers, S.L., Wang, F., Pu, X.A., Nelson, R.J., and Ma, J. (2009). Cytoplasmic prion protein induces forebrain neurotoxicity. Biochim Biophys Acta.
96. Wang, X., Wang, F., Arterburn, L., Wollmann, R., and Ma, J. (2006). The interaction between cytoplasmic prion protein and the hydrophobic lipid core of membrane correlates with neurotoxicity. J Biol Chem 281, 13559-13565.
97. Wang, X., Wang, F., Sy, M.S., and Ma, J. (2005). Calpain and other cytosolic proteases can contribute to the degradation of retro-translocated prion protein in the cytosol. J Biol Chem 280, 317-325.
98. Weissmann, C., Fischer, M., Raeber, A., Büeler, H., Sailer, A., Shmerling, D., Rülicke, T., Brandner, S., and Aguzzi, A. (1996). The role of PrP in pathogenesis of experimental scrapie. Cold Spring Harb Symp Quant Biol 61, 511-522.
99. Winklhofer, K.F., Heske, J., Heller, U., Reintjes, A., Muranji, W., Moarefi, I., and Tatzelt, J. (2003). Determinants of the in vivo-folding of the prion protein: a bipartite function of helix 1 in folding and aggregation. J Biol Chem 278, 14961-14970.
100. Winklhofer, K.F., Tatzelt, J., and Haass, C. (2008). The two faces of protein misfolding: Gain and loss of function in neurodegenerative diseases. EMBO J 27, 336-349.
101. Yedidia, Y., Horonchik, L., Tzaban, S., Yanai, A., and Taraboulos, A. (2001). Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. Embo J 20, 5383-5391.
102. Yost, C.S., Lopez, C.D., Prusiner, S.B., Myers, R.M., and Lingappa, V.R. (1990). Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature 343, 669-672.
103. Zanusso, G., Petersen, R.B., Jin, T., Jing, Y., Kanoush, R., Ferrari, S., Gambetti, P., and Singh, N. (1999). Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J Biol Chem 274, 23396-23404.